Article
Oncologic Outcomes by Pathogenic BRCA Mutation Status in Young Luminal Breast Cancer: A Propensity-Matched Cohort.
JCO precision oncology - 1 Jan 2026
Park Woong Ki, Nam Seok Jin, Kim Seok Won, Lee Jeong Eon, Yu Jonghan, Lee Se Kyung, Ryu Jai Min, Ahn Jin Seok, Park Yeon Hee, Kim Ji-Yeon, Chae Byung Joo
Abstract excerpt
PURPOSE: Young patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative tumors often exhibit poor outcomes. This study evaluated whether BRCA mutation contributes to prognosis by comparing oncologic outcomes according to BRCA status. MATERIALS AND METHODS: We conducted a retrospective study of a prospective institutional cohort. Among 1,025 patients 40 years and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
